Vulvo-vaginal stromal tumours – Case series of a rare entity from an oncology centre in India

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY
Biswajit Dash , Sushmita Rath , Bharat Rekhi , Neha Mittal , Rohini Kulkarni , T.S. Shylasree , Amita Maheshwari
{"title":"Vulvo-vaginal stromal tumours – Case series of a rare entity from an oncology centre in India","authors":"Biswajit Dash ,&nbsp;Sushmita Rath ,&nbsp;Bharat Rekhi ,&nbsp;Neha Mittal ,&nbsp;Rohini Kulkarni ,&nbsp;T.S. Shylasree ,&nbsp;Amita Maheshwari","doi":"10.1016/j.gore.2024.101464","DOIUrl":null,"url":null,"abstract":"<div><p>Vulvo-vaginal stromal tumours are a rare and diverse group of mesenchymal neoplasms unique to hormone-responsive stroma of the vulva and vagina. These tumours are mostly benign, except for the locally aggressive deep angiomyxomas. Often these tumours pose diagnostic challenges, resembling certain malignant vulvo vaginal tumours.</p><p>This case series highlights clinicopathological features of four angiomyxomas; a single angiomyofibroblastoma, and another superficial myofibroblastoma, including their clinical outcomes. All patients were in their 4th or 5th decade of life. Only 1/4 angiomyxomas was correctly diagnosed at the referring hospitals. Three out of four patients harbouring angiomyxomas achieved clinical remission post-surgery, while one patient was lost to follow-up. By immunohistochemistry, tumor cells showed variable positivity for desmin, SMA, ER, and PR, and negativity for S100P and CD34. The angiomyofibroblastoma was initially misdiagnosed as a liposarcoma, and the patient was lost to follow-up after diagnosis. Immunohistochemically, the tumor cells were diffusely positive for SMA and ER; weakly and focally positive for desmin, and negative for AE1/AE3, CD34, and S100P. The patient with superficial myofibroblastoma is in clinical remission post-excision with an 18-month follow-up. Immunohistochemically, the tumor cells showed CD34 positivity. Therapeutically, none of the patient received adjuvant treatment, except for a single patient with angiomyxoma, who underwent chemoradiation for a synchronous cancer cervix post-surgery.</p><p>This case series provides valuable insights into the clinical heterogeneity, diagnostic intricacies, and outcomes of vulvo-vaginal stromal tumours from an oncology centre in India, further contributing to a better understanding of these rare tumours.</p></div>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352578924001437/pdfft?md5=dc998b3fca10262450d407a403e2512b&pid=1-s2.0-S2352578924001437-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352578924001437","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Vulvo-vaginal stromal tumours are a rare and diverse group of mesenchymal neoplasms unique to hormone-responsive stroma of the vulva and vagina. These tumours are mostly benign, except for the locally aggressive deep angiomyxomas. Often these tumours pose diagnostic challenges, resembling certain malignant vulvo vaginal tumours.

This case series highlights clinicopathological features of four angiomyxomas; a single angiomyofibroblastoma, and another superficial myofibroblastoma, including their clinical outcomes. All patients were in their 4th or 5th decade of life. Only 1/4 angiomyxomas was correctly diagnosed at the referring hospitals. Three out of four patients harbouring angiomyxomas achieved clinical remission post-surgery, while one patient was lost to follow-up. By immunohistochemistry, tumor cells showed variable positivity for desmin, SMA, ER, and PR, and negativity for S100P and CD34. The angiomyofibroblastoma was initially misdiagnosed as a liposarcoma, and the patient was lost to follow-up after diagnosis. Immunohistochemically, the tumor cells were diffusely positive for SMA and ER; weakly and focally positive for desmin, and negative for AE1/AE3, CD34, and S100P. The patient with superficial myofibroblastoma is in clinical remission post-excision with an 18-month follow-up. Immunohistochemically, the tumor cells showed CD34 positivity. Therapeutically, none of the patient received adjuvant treatment, except for a single patient with angiomyxoma, who underwent chemoradiation for a synchronous cancer cervix post-surgery.

This case series provides valuable insights into the clinical heterogeneity, diagnostic intricacies, and outcomes of vulvo-vaginal stromal tumours from an oncology centre in India, further contributing to a better understanding of these rare tumours.

外阴阴道间质瘤--印度一家肿瘤中心的罕见病例系列
外阴阴道间质瘤是外阴和阴道激素反应性间质肿瘤中特有的一种罕见的、多样化的间质肿瘤。除局部侵袭性深血管瘤外,这些肿瘤大多为良性。本病例系列重点介绍了四种血管肌瘤、一种血管肌纤维母细胞瘤和另一种浅表肌纤维母细胞瘤的临床病理特征,包括其临床结果。所有患者均处于人生的第四或第五个十年。只有 1/4 的血管肌瘤在转诊医院得到了正确诊断。四名血管肌瘤患者中有三人在手术后临床症状得到缓解,一名患者失去了随访机会。免疫组化结果显示,肿瘤细胞的 desmin、SMA、ER 和 PR 呈不同程度的阳性,S100P 和 CD34 呈阴性。血管肌纤维母细胞瘤最初被误诊为脂肪肉瘤,患者在确诊后失去了随访机会。免疫组化结果显示,肿瘤细胞的SMA和ER呈弥漫阳性,desmin呈弱阳性和局灶阳性,AE1/AE3、CD34和S100P呈阴性。该浅表肌纤维母细胞瘤患者在切除术后随访18个月,临床症状得到缓解。免疫组化结果显示,肿瘤细胞呈 CD34 阳性。在治疗方面,除了一名血管肌瘤患者在手术后接受了宫颈同步癌的化疗放疗外,其他患者均未接受辅助治疗。该系列病例为印度一家肿瘤中心的外阴阴道间质瘤的临床异质性、诊断复杂性和预后提供了宝贵的见解,有助于更好地了解这些罕见肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gynecologic Oncology Reports
Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-
CiteScore
2.00
自引率
0.00%
发文量
183
审稿时长
41 days
期刊介绍: Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信